Selecting and Sequencing Targeted and Immunotherapy Regimens for Patients With RCC

Navigating Evolving Standards of Care in RCC: Novel Targeted and Immunotherapy OptionsПодробнее

Understanding and Working With New Immunotherapeutic and Targeted Management Models in Advanced RCCПодробнее

Dr. Atkins on Sequencing of Immunotherapy Combination Regimens for RCCПодробнее

Dr. Chowdhury on Sequencing of Immunotherapy Regimens for RCCПодробнее

Selecting Therapy for Poor-Risk Advanced RCCПодробнее

RCC: Current Applications, Controversies, and Future Use of Immunotherapy and Targeted AgentsПодробнее

Dr. Rini on Sequencing of Immunotherapy Combinations in RCCПодробнее

How to select 1st line therapy for metastatic renal cell cancer?Подробнее

RCC MasterClass and Clinical Consult: Novel Immune and Targeted TherapiesПодробнее

Dr. Motzer on First-Line Treatment of Metastatic RCCПодробнее

Selecting immunotherapy for RCCПодробнее

Advanced RCC Treatment SelectionПодробнее

Clinically Meaningful Outcomes Among Expanding Treatment Options in RCCПодробнее

Immunotherapy and targeted therapy for advanced aRCCПодробнее

Advanced RCC: Prognosis and Therapy SelectionПодробнее

Immunotherapy-based management of metastatic clear-cell and variant RCC: What can we achieve?Подробнее

Second-Line Treatment Options for Advanced RCCПодробнее

Selecting I-O Agents and Combinations for Patients With RCCПодробнее

Immunotherapy-based combinations for advanced/metastatic renal cell carcinoma: ASCO GU 2023Подробнее